शुभ दीपावलीDiwali offer: 3 months free on yearly plans · ends 11 NovSee plans
BSEBDH INDUSTRIES LTD.· Pharmaceuticals & BiotechnologyMinimalNeutral
Announced Wed, 7 Oct, 2026 · 15:08 IST

Routine dematerialisation certificate for Q2 FY26-27 filed with BSE

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
-3.8%Reaction day
₹499.80
prior close
₹481.00
announcement price
In-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-0.2%-3.5% vs market
Pharmaceuticals peers, median of 170sector-0.3%-3.4% vs sector

On the reaction day the stock moved 3.5 pts less than Nifty Microcap 250 and 3.4 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
+0.0
10m
+0.0
15m
+0.0
30m
—
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
-3.8-0.2-3.5-0.3-3.4
Next day
-5.0-3.0-2.0-2.7-2.2
2d
-6.3-2.7-3.5-2.7-3.6
3d
-11.4-1.9-9.5-2.6-8.8
4d
-12.0-1.7-10.2-3.0-9.0
5d
-6.0-1.0-4.9-2.9-3.0
1w
-12.1-2.0-10.2-3.4-8.7
15d
-18.0-6.6-11.3-3.4-14.6
1m
—————
2m
—————
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 170Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

BDH Industries submitted a compliance certificate under SEBI Regulation 74(5) for the quarter ended 30 September 2026. The certificate, issued by the company's Registrar and Share Transfer Agent MUFG Intime India, confirms that securities received from depository participants for dematerialisation were verified, listed on stock exchanges, and recorded in the register of members within prescribed timelines. This is a standard quarterly procedural filing.

Likely market impact

No impact on shareholders or stock price; this is a routine regulatory compliance filing with no material information.